Data / Form D filings / Swift Cardiovascular, Inc.
Swift Cardiovascular, Inc.: Form D filing
Swift Cardiovascular, Inc., a biotechnology company in Durham, NC, filed a Form D with the SEC in 2026. The latest, on September 24, 2026, reports $810,000 sold of a $1.5 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 110 SWIFT AVENUE, Durham, NC, 27705
- Phone
- (919) 630-7851
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2117135
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | New notice | $1,500,000 | $810,000 | $690,000 | 7 | Jan 21, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey Harold Lawson | Executive Officer, Director | |
| Kemal Vincent Schankereli | Director | |
| Howard Vincent Kelly | Director | |
| Richard Francis Murphy | Executive Officer | |
| Jospeh Blakely Long | Executive Officer |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Sep 21, 2026 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Swift Cardiovascular, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.